TOKYO–(BUSINESS WIRE)–MUFG today announced partial corrections to �Consolidated Summary Report <under Japanese GAAP> for the fiscal year ended March 31, 2022 disclosed on May 16, 2022, as shown in the Appendix.
Appendix
Corrections:
Consolidated Summary Report <under Japanese GAAP> for the fiscal year ended March 31, 2022 (Summary information)
1. Consolidated Financial Data for the Fiscal Year ended March 31, 2022
(3) Cash Flows
* The corrected figures are underlined.
(Before Correction)
|
Cash Flows from |
Cash Flows from |
Cash Flows from |
Cash and Cash Equivalents |
Fiscal year ended | million yen | million yen | million yen | million yen |
March 31, 2022 | 9,635,443 | (2,202,726) | (875,972) | 110,763,205 |
March 31, 2021 | 34,904,946 | (10,140,343) | (436,071) | 102,980,711 |
(After Correction)
|
Cash Flows from |
Cash Flows from |
Cash Flows from |
Cash and Cash Equivalents |
Fiscal year ended | million yen | million yen | million yen | million yen |
March 31, 2022 | 9,839,899 | (2,202,726) | (1,080,428) | 110,763,205 |
March 31, 2021 | 34,904,946 | (10,140,343) | (436,071) | 102,980,711 |
The above is part of the revision of the consolidated financial statements of Mitsubishi UFJ Financial Group based on Japan accounting standards for the fiscal year ended March 31, 2022. Please refer to MUFG’s website for more information.
Contacts
Takeshi Ito
Public Relations Division
Tokyo/Head Office
Mitsubishi UFJ Financial Group, Inc.
T +81-3-5218-1815
E takeshi_12_itou@mufg.jp
HOHHOT, CHINA - Media OutReach Newswire - 23 December 2024 - China's National Forestry and…
HONG KONG SAR - EQS Newswire - 23 December 2024 - Novautek Autonomous Driving Limited…
JAKARTA, INDONESIA - Media OutReach Newswire - 23 December 2024 - V-GREEN and PT Xanh…
Increase in opportunities predicted for high-speed optical transceivers and miniaturized connectivity solutions to address data-intensive…
HONG KONG SAR - Media OutReach Newswire - 23 December 2024 - DYXnet, a wholly-owned…
CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…